10 March 2021 - 11 March 2021

Back to all short courses

 Introduction to Modeling Methods

LEVEL - Introductory
TRACK - Health Policy & Regulatory 
LENGTH: 4 Hour | 2 Consecutive Days, 2 Hours per Day

Register Now

Wednesday, 10 March 2021 
09:00-11:00 Eastern Standard Time (EST)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00 Central European Time (CET)

Thursday, 11 March 2021 
09:00-11:00 Eastern Standard Time (EST)
14:00- 16:00 Greenwich Mean Time (GMT)
15:00-17:00 Central European Time (CET)

Basic Schedule: 

Class Time: 2 hours per day

Click for time zone conversion


The US healthcare system is a hybrid system that provides access to care via various channels and means. It can be categorized as: governmental systems (Medicare, Medicaid, Veterans Health Administration, and Department of Defense, etc), private markets (privately sponsored regional and national health plans), and providers assuming responsibility for access and coverage via mechanisms such as Provider Networks, Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), etc. These elements are quite heterogeneous and characterized by different coverage and access mechanisms. This introductory course will cover the roots of the current US system, its evolutionary process, and the consequent independence of these different parts of the system. The focus will be on value and affordability as defined by cost, access, and quality. While all hold value and affordability as important goals, the different stakeholders take various perspectives and define these goals differently. This results in different objectives, incentives, and principles under which they operate. The intent of this course is to better understand characteristics of the different parts of the US healthcare system and the role of various decision makers within it. The course will cover their structure, scope, processes, and perspectives as well as their approach to balancing access, costs and quality. The course will also cover how industry and others produce evidence to support access and reimbursement decisions and how the evidence is used by decision makers. This session will facilitate the increased level of understanding of these disparate systems and emphasize the need to effectively communicate evidence to various access decision makers to support and enhance evidence driven decision making on value and affordability. This course is designed for those having limited experience in understanding the structure of the US Healthcare system, including its various subsystems and how they operate. The course will focus on how these entities differ in perspectives, coverage mechanisms, and the means and evidence they use to define and achieve both value (access and quality) and affordability.



Finn Børlum Kristensen, MD, PhD
University of Southern Denmark
Hilleroed, Denmark

Jessica Daw, PharmD, MBA
Senior Director
UPMC Health Plan
Pittsburgh, PA, USA

James Murray, PhD
Research Fellow
Eli Lilly and Company
Carmel, IN, USA

Laura Pizzi, PharmD, MPH, RPh
Professor & Director
Health Outcomes, Policy, and Economics (HOPE) Program
Rutgers University
Piscataway, NJ, USA 


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now